Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT00977158

Microbiota of the Respiratory Flora in Children With Cystic Fibrosis During the First Year of Life

Status
Withdrawn
Phase
Study type
Observational
Enrollment
0 (actual)
Sponsor
Tufts Medical Center · Academic / Other
Sex
All
Age
1 Day – 3 Months
Healthy volunteers
Not accepted

Summary

The goal of this study is characterize the changes in bacterial diversity of the upper respiratory tracts of infants with cystic fibrosis (CF). Another goal is to determine when CF patients become colonized with pathogenic bacteria that are responsible for the lethal lung damage in children with CF. Ten subjects will be recruited into the study. Throat swabs will be collected at 6-8 weeks of age, 3 months, 6 months, 9 months, and 12 months of age in order to chart any changes in the bacterial populations of the respiratory tract. Clinical data will also be collected to evaluate the possible influence of external factors on changes in the microbial communities. This study will provide preliminary data on whether probiotics can eradicate the colonization of the respiratory tract by pathogenic bacteria.

Conditions

Interventions

TypeNameDescription
PROCEDUREThroat SwabSwabs will be moistened in sterile 0.9% sodium chloride solution and rotated in the throat and processed for bacterial cultures and for bacterial DNA extraction.

Timeline

Start date
2011-05-01
First posted
2009-09-15
Last updated
2015-03-18

Locations

2 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT00977158. Inclusion in this directory is not an endorsement.